Kang JK, Ku IS, Cha JY, Cho HY, Kim HH, Kim YJ, Ree SS, Bae EK, Na YJ, Kim KT, Cho SH, Cho SH, Hwang YY, Moon H
- KMID: 2262708
-
Korean J Obstet Gynecol.
-
2002 Apr;45(4):593-601.
OBJECTIVES: It is now conventional practice to use human chorionic gonadotropin (hCG) as the marker of tumor activity in gestational trophoblastic disease (GTD). The interpretation of serial serum beta-hCG regression...